RET receptor expression in thyroid follicular epithelial cell-derived tumors

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2845-2849

  Bunone, Giuseppe ^a   Uggeri, Mauro ^a   Mondellini, Piera ^a   Pierotti, Marco A ^a   Bongarzone, Italia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ARTICLE; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTO ONCOGENE; RNA ANALYSIS; SIGNAL TRANSDUCTION; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; BASE SEQUENCE; BLOTTING, WESTERN; DROSOPHILA PROTEINS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034213657     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Williams, E. D. The aetiology of thyroid tumours. Clin. Endocrinol. Metab., 8: 193-207, 1979.
2. Pierotti, M. A., Bongarzone, I., Borrello, M. G., Greco, A., Pilotti, S., and Sozzi, G. Cytogenetics and molecular genetics of the carcinomas arising from the thyroid epithelial follicular cells. Genes Chromosomes Cancer, 16: 1-14, 1996.
3. Suarez, H. G., du Villard, J. A., Severino, M., Caillou, B., Schlumberger, M., Tubiana, M., Parmentier, C., and Monier, R. Presence of mutations in all three ras genes in human thyroid tumors. Oncogene, 5: 565-570, 1990.
4. Lemoine, N. R., Staddon, S. L., Bond, J., Wyllie, F. S., Shaw, J. J., and Wynford-Thomas, D. Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene. Oncogene, 5: 1833-1837, 1990.
5. Namba, H., Rubin, S., and Fagin, J. A. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol., 4: 1474-1479, 1990.
6. Manenti, G., Pilotti, S., Re, F. C., Della Porta, G., and Pierotti, M. A. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Eur. J. Cancer, 30A: 987-993, 1994.
7. Donghi, R., Longoni, A., Pilotti, S., Michieli, P., Della Porta, G., and Pierotti, M. A. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Investig., 91: 1753-1760, 1993.
8. Fagin, J. A. Tumor suppressor genes in human thyroid neoplasms: p53 mutations are associated undifferentiated thyroid cancers. J. Endocrinol. Investig., 18: 140-142, 1995.
9. Ponder, B. A. The phenotypes associated with RET mutations in the multiple endocrine neoplasia type 2 syndrome. Cancer Res., 59: 1736s-1742s, 1999.
10. Bongarzone, I., Butti, M. G., Coronelli, S., Borrello, M. G., Santoro, M., Mondellini, P., Pilotti, S., Fusco, A., Della Porta, G., and Pierotti, M. A. Frequent activation of RET protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res., 54: 2979-2985, 1994.
11. Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Porta, G., Fusco, A., and Vecchio, G. PTC is a novel rearranged form of the RET proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell, 60: 557-563, 1990.
12. Bongarzone, I., Monzini, N., Borrello, M. G., Carcano, C., Ferraresi, G., Arighi, E., Mondellini, P., Della Porta, G., and Pierotti, M. A. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of RET tyrosine kinase and the regulatory subunit RIa of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol., 13: 358-366, 1993.
13. Klugbauer, S., Lengfelder, E., Demidchik, E. P., and Rabes, H. M. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene, 11: 2459-2467, 1995.
14. Pang, X. P., Hershman, J. M., Chung, M., and Pekary, A. E. Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology, 125: 1783-1788, 1989.
15. Borrello, M. G., Pelicci, G., Arighi, E., De Filippis, L., Greco, A., Bongarzone, I., Rizzetti, M. G., Pelicci, P. G., and Pierotti, M. A. The oncogenic versions of the RET and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene, 9: 1661-1668, 1994.
16. Minoletti, F., Butti, M. G., Coronelli, S., Miozzo, M., Sozzi, G., Pilotti, S., Tunnacliffe, A., Pierotti, M. A., and Bongarzone, I. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2. Genes Chromosomes Cancer, 11: 51-57, 1994.
17. Volante, M., Papotti, M., Roth, J., Saremaslani, P., Speel, E. J. M., Lloyd, R. V., Carney, J. A., Heitz, P. U., Bussolati, G., and Komminoth, P. Mixed medullary-follicular thyroid carcinoma. Am. J. Pathol., 155: 1499-1509, 1999.
18. Matias-Guiu, X. Mixed medullary and follicular carcinoma of the thyroid. Am. J. Pathol., 155: 1413-1418, 1999.
19. Borrello, M. G., Alberti, L., Arighi, E., Bongarzone, I., Battistini, C., Bardelli, A., Pasini, B., Piutti, C., Rizzetti, M. G., Mondellini, P., Radice, M. T., and Pierotti, M. A. The full oncogenic activity of RET/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ. Mol. Cell. Biol., 16: 2151-2163, 1996.
20. Arighi, E., Alberti, L., Torriti, F., Ghizzoni, S., Rizzetti, M. G., Pelicci, G., Pasini, B., Bongarzone, I., Piutti, C., Pierotti, M. A., and Borrello, M. G. Identification of SHC docking site on RET tyrosine kinase. Oncogene, 14: 773-782, 1997.
21. Lorenzo, M. J., Gish, G. D., Houghton, C., Stonehouse, T. J., Pawson, T., Ponder, B. A. J., and Smith, D. P. RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2. Oncogene, 14: 763-771, 1997.
22. Alberti, L., Borrello, M. G., Ghizzoni, S., Torriti, F., Rizzetti, M. G., and Pierotti, M. A. GRB2 binding to the different isoforms of RET tyrosine kinase. Oncogene, 17: 1079-1087, 1998.
23. Chiariello, E., Visconti, R., Carlomagno, F., Melillo, R. M., Bucci, C., de Franciscis, V., Fox, G. M., Jing, S., Coso, O. A., Gutkind, J. S., Fusco, A., and Santoro, M. Signalling of the RET receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by RET. Oncogene, 16: 2435-2445, 1999.